Genocea’s mission is to help conquer cancer through targeted vaccines and immunotherapies. Using our revolutionary ATLAS™ platform to identify true T cell antigens, we are creating new lifelines for cancer patients by listening to and learning from the immune system.

Our ATLAS platform uniquely identifies true antigens (that trigger effective T cell responses) rather than relying on poorly predictive in silico-based methods. By using ex vivo biological assays to identify and characterize antigens relevant to patients, we aim to create best-in-class cancer vaccines.

MORE

Genoceans make waves. We seek new colleagues who are dedicated to our mission and who will thrive in a dynamic, driven, and results-oriented environment.

MORE